360° SearchNetwork Hot Spots Trends Time Series

Ron Cohen

Type: Person

Name: Ron Cohen

First reported May 14 2013 - Updated May 15 2013 - 2 reports

Yucca Valley recall effort moves forward (Photos)

Yesterday the effort to recall two members of the Yucca Valley Town Council, Robert Lombardo and George Huntington, moved one step closer to fruition. Ron Cohen, the lead proponent and spokesperson for Concerned Citizens whose website is www... ... [Published Examiner.com - May 15 2013]

Entities: George Huntington, Ron Cohen

First reported May 13 2013 - Updated May 13 2013 - 1 reports

Acorda Therapeutics Inc

Acorda Therapeutics reports net loss for Q1, reiterates guidance for 2013

Acorda Therapeutics, Inc., a biopharmaceutical company, has reported that net loss for the first quarter ended March 31, 2013 was $1.14 million, or $0.03 loss per diluted share, compared to a net income of $7.85 million, or $0.19 per diluted share, for ... [Published Individual.com - May 13 2013]

Entities: Acorda Therapeutics Inc, Ron Cohen, Operating Income

First reported May 07 2013 - Updated May 07 2013 - 1 reports

Recall begins for two Yucca Valley Town Council members

YUCCA VALLEY -- A recall is under way against two recently re-elected members of the Town Council who opponents charge have not been accountable to the town's 20,000 residents.Notices of intent to circulate a recall petition were served April 30 to George ... [Published Redlands Daily Facts - May 07 2013]

Entities: George Huntington, Ron Cohen, Fiduciary, Census, Ethical

First reported May 04 2013 - Updated May 04 2013 - 1 reports

Acorda Therapeutics Management Discusses Q1 2013 Results - Earnings Call Transcript

8:30 AM ETOperatorThank you for holding. Welcome to the Acorda Therapeutics First Quarter 2013 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being taped at the company's request.Now, I would like to introduce ... [Published Seeking Alpha - May 04 2013]

Entities: Acorda Therapeutics Inc, Qutenza, Ron Cohen, Valium, Tizanidine

First reported Apr 23 2013 - Updated Apr 23 2013 - 1 reports

Raff and Cohen of Besen & Associates secure $20.6 million sale totaling 35,638 s/f

Glenn Raff, Besen & AssociatesRon Cohen, Besen & Associates335 East 33rd Street - New York, NYManhattan, NY Besen & Associates secured the $20.6 million sale of the apartment buildings located at 243, 244, 247, 333 & 335 East 33rd St., in the Murray Hill ... [Published New York Real Estate Journal - Apr 23 2013]

Entities: Ron Cohen, Manhattan, Murray Hill

First reported Apr 21 2013 - Updated Apr 21 2013 - 1 reports

The making of Sharrif Floyd

SOME TIME Thursday night, probably early, Sharrif Floyd's incessant nervous foot tapping is going to cease when NFL commissioner Roger Goodell strides to the Radio City Music Hall podium and calls his name.Floyd will rise slowly, dressed impeccably in ... [Published Individual.com - Apr 21 2013]

Entities: Ron Cohen, Mike Wallace, Greg Garrett, George Washington

First reported Apr 16 2013 - Updated Apr 16 2013 - 2 reports

Acorda's MS drug proves to help stroke patients walk again, study finds

A phase II study proved a drug that helps multiple sclerosis patients walk can also help stroke patients walk, Medical News Today reported.Acorda Therapeutics, which makes Ampyra (dalfampridine), said patients with post-stroke deficits – such as impaired ... [Published FOXNews.com - Apr 16 2013]

Entities: Multiple Sclerosis, Ron Cohen, Placebo, Drugs

First reported Apr 16 2013 - Updated Apr 16 2013 - 2 reports

MS Drugs Helps Stroke Patients Walk: Study

Acorda Therapeutics, maker of the drug Ampyra to improve walking in multiple sclerosis patients, rose to its highest value in more than two years after the company said a small study showed the medicine also helped people who have had strokes.Acorda gained ... [Published NewsMax.com - Apr 16 2013]

Entities: Multiple Sclerosis, Ron Cohen, Drugs, Patient

First reported Apr 15 2013 - Updated Apr 16 2013 - 6 reports

Acorda CEO: Ampyra Helping Stroke Victims Walk Better

Acorda Therapeutics CEO Dr. Ron Cohen discusses what his company has planned for 2013, and how Ampyra is helping people with post-stroke deficits. ... [Published CNBC - Apr 16 2013]

Entities: Ron Cohen, Acorda Therapeutics Inc

First reported Apr 16 2013 - Updated Apr 16 2013 - 1 reports

Acorda Therapeutics, Inc. - Special Call

Acorda Therapeutics, Inc. ( ACOR ) April 15, 2013 8:30 am ET Executives Jeff Macdonald Ron Cohen - Founder, Chief Executive Officer, President and Director Andrew R. Blight - Chief Scientific Officer Analysts Joel D. Sendek - Stifel, Nicolaus ... [Published Healthcare Sector and Stocks Analysis from Seek ... - Apr 16 2013]

Entities: Acorda Therapeutics Inc, Jeff Macdonald, INC Research, Raghuram Selvaraju, Ron Cohen

First reported Jan 07 2013 - Updated Jan 07 2013 - 1 reports

Acorda Therapeutics, Inc. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-07-2013 11:00 AM

Acorda Therapeutics, Inc. ( ACOR ) January 07, 2013 2:00 pm ET Executives Ron Cohen - Founder, Chief Executive Officer, President and Director Analysts Geoffrey C. Meacham - JP Morgan Chase & Co, Research Division Presentation Geoffrey ... [Published Healthcare Sector and Stocks Analysis from Seek ... - Jan 07 2013]

Entities: Acorda Therapeutics Inc, JPMorgan Chase & Co, Healthcare Conference, Ron Cohen

First reported Dec 19 2012 - Updated Dec 19 2012 - 1 reports

Target the Gun Profiteers Makers

There are a slew of newly visible, Serious & Constructive ideas about improving gun safety in America, shaken loose by the latest tragedy. Mr. Charles P. Pierce at Esquire starts near the top of the food chain : If you read nothing else in the wake ... [Published Balloon Juice - Dec 19 2012]

Entities: Tobacco, Gun Control, Ronald Reagan, David Satcher, Ron Cohen

Quotes

..." Cohen said, "if they don't step down, the recall is on."

Yucca Valley town council recall effort advances [Published KESQ - May 14 2013]

"ampyra sales were pressured in the first part of the quarter, consistent with the seasonal pattern we have seen in prior years and in line with our internal projections. sales rebounded strongly in march and continued to increase in april. underlying consumer demand also remained strong and we are maintaining our 2013 ampyra net sales guidance of $285-$315 million" said Ron Cohen, Acorda Therapeutics' president and CEO

Acorda Therapeutics reports net loss for Q1, reiterates guidance for 2013 [Published Individual.com - May 13 2013]

"the bottom line is they're not paying any attention to yucca valley" said Ron Cohen, a spokesman for a recall committee he said now consists of 25 people...

Recall begins for two Yucca Valley Town Council members [Published Redlands Daily Facts - May 07 2013]

...heavily on attracting and retaining the most talented and collaborative people in the industry," said Ron Cohen, M D , Acorda’s President and CEO. "we continually work to provide an environment that incorporates a sense of fun, while fostering teamwork, integrity and professional growth. the best places to work recognition highlights that acorda has maintained a strong corporate culture that values the contributions of all of our associates, even as we’ve grown significantly over the past few years."

Acorda Therapeutics Recognized as One of the Best Places to Work in New York State for Third Cons ... [Published Business Wire - May 06 2013]

More Content

sort by: Date \| Relevance
Acorda Therapeutics to Present at the UBS Globa... [Published Business Wire - May 15 2013]
Acorda Therapeutics to Present at the UBS Globa... [Published Business Wire Health News - May 15 2013]
Yucca Valley recall effort moves forward (Photos) [Published Examiner.com - May 15 2013]
Yucca Valley town council recall effort advances [Published KESQ - May 14 2013]
Acorda Therapeutics reports net loss for Q1, re... [Published Individual.com - May 13 2013]
Recall begins for two Yucca Valley Town Council... [Published Redlands Daily Facts - May 07 2013]
Acorda Therapeutics Recognized as One of the Be... [Published Business Wire - May 06 2013]
Acorda Therapeutics Management Discusses Q1 201... [Published Seeking Alpha - May 04 2013]
Acorda Therapeutics Earnings: Here’s Why Shares... [Published Wall St. Cheat Sheet - May 02 2013]
Acorda Therapeutics Announces Positive AMPYRA d... [Published Equities.com - Apr 24 2013]
Raff and Cohen of Besen & Associates secure $20... [Published New York Real Estate Journal - Apr 23 2013]
BIO Elects New Chair, Officers, and Board Members [Published Business Wire - Apr 23 2013]
The making of Sharrif Floyd [Published Individual.com - Apr 21 2013]
Acorda Therapeutics Reports Positive AMPYRA (da... [Published Equities.com - Apr 18 2013]
Acorda's MS drug proves to help stroke patients... [Published FOXNews.com - Apr 16 2013]
MS Drugs Helps Stroke Patients Walk: Study [Published NewsMax.com - Apr 16 2013]
Acorda pursues stroke indication for MS drug Am... [Published Pharma Times - Apr 16 2013]
Acorda Therapeutics' CEO Hosts Revision of the ... [Published Seeking Alpha - Apr 16 2013]
Acorda Therapeutics reports positive data from ... [Published News-Medical.Net - Apr 16 2013]
Acorda Therapeutics, Inc. - Special Call [Published Healthcare Sector and Stocks Analysis from Seek ... - Apr 16 2013]
Acorda CEO: Ampyra Helping Stroke Victims Walk ... [Published CNBC - Apr 16 2013]
Acorda Soars as Ampyra MS Drug Helps Walking in... [Published Washington Post - Apr 15 2013]
Acorda Therapeutics Drug Helps Stroke Patients ... [Published BioSpace - Apr 15 2013]
Acorda Stock Climbs on Post-stroke Study [Published Xconomy - Apr 15 2013]
Acorda Drug Helps Stroke Patients Walk Better [Published TheStreet.com - Apr 15 2013]
Drug That Helps Multiple Sclerosis Patients Wal... [Published Forbes.com - Apr 15 2013]
Acorda Therapeutics (ACOR) Says AMPYRA Improved... [Published Street Insider - Apr 15 2013]
Acorda Therapeutics Reports Positive AMPYRA Pha... [Published RTTNews.com - Apr 15 2013]
ACORDA THERAPEUTICS INC: Acorda Therapeutics An... [Published 4 Traders - Apr 15 2013]
Acorda Therapeutics Announces Positive AMPYRA® ... [Published Business Wire - Apr 15 2013]

Blogs

sort by: Date \| Relevance
Acorda Therapeutics Earnings: Here’s Why Shares... [Published Wall St. Cheat Sheet - May 02 2013] Acorda Therapeutics, Inc. ( NASDAQ:ACOR ) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares ...
Acorda, Klick Health continue online collaboration [Published Medad Blog - Feb 25 2013] By Mia Burns Acorda Therapeutics, Inc. and partner Klick Health have announced that the Nielsen Norman Group has named Acorda’s intranet site as one of the 10 best in the world. Synapse is the name of Acorda’s intranet, and it launched in late 2011. ...
The Allen alert – The Week [Published MaritimeSecurity.Asia - Feb 25 2013] On April 19, 2012, the Ministry of Defence alerted the Central Bureau of Investigation and the Directorate General of Economic Enforcement about the leak of classified documents related to defence procurement. The ministry was tipped-off in style—through ...
Acorda Therapeutics Earnings: Everything You Mu... [Published Wall St. Cheat Sheet - Feb 13 2013] Acorda Therapeutics, Inc. ( NASDAQ:ACOR ) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. The revenue beat is a positive sign to shareholders seeking high growth out of the company. Shares are down 0%. Show ...
Target the Gun Profiteers Makers [Published Balloon Juice - Dec 19 2012] There are a slew of newly visible, Serious & Constructive ideas about improving gun safety in America, shaken loose by the latest tragedy. Mr. Charles P. Pierce at Esquire starts near the top of the food chain : If you read nothing else in the wake ...

Audio/Video

sort by: Date \| Relevance
ObamaCare, Fiscal Cliff a Threat to Biotech Ind... [Published FOX Business - Video - Dec 06 2012]

Press Releases

sort by: Date \| Relevance
Acorda Therapeutics to Present at the UBS Globa... [Published Business Wire - May 15 2013]
Acorda Therapeutics to Present at the UBS Globa... [Published Business Wire Health News - May 15 2013]
Acorda Therapeutics Recognized as One of the Be... [Published Business Wire - May 06 2013]
BIO Elects New Chair, Officers, and Board Members [Published Business Wire - Apr 23 2013]
Acorda Therapeutics Announces Positive AMPYRA® ... [Published Business Wire - Apr 15 2013]